In breast cancers, TPX2 mRNA levels have been reported as a strong predictor of aggressive behavior, reduced response to therapy, and poor survival, while depletion of TPX2 can suppress proliferation and promote apoptosis [16–22]. Here, TPX2 is linked to breast cancer.